Chemours (CC) FY2018 results: revenue $6.6 billion, up 7.4% on the year
Chemours Co. (CC) reported revenue of $6.6 billion for fiscal 2018, the year ended 31 December 2018, up 7.4% on the year before. Net income was $995 million, up 33.4%, and diluted earnings per share $5.45. The figures are the company's own, from the 10-K it filed with the SEC on 15 February 2019.
Revenue
$6.6 billion
+7.4% on the year
FY2013FY2018
Operating margin
17.8%
15.9% a year earlier
FY2013FY2018
Net income
$995 million
+33.4% on the year
FY2013FY2018
Diluted EPS
$5.45
+39.4% on the year
FY2013FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
6,638
6,183
5,400
+7.4%
Cost of revenue
4,667
4,438
4,297
+5.2%
Gross profit
1,971
1,745
1,103
+13.0%
Gross margin
29.7%
28.2%
20.4%
Research and development
82.0
81.0
81.0
+1.2%
Selling, general and administrative
657
626
946
+5.0%
Operating income
1,183
981
-94.0
+20.6%
Operating margin
17.8%
15.9%
-1.7%
Interest expense
195
214
219
-8.9%
Pre-tax income
1,155
912
-11.0
+26.6%
Income tax
159
165
-18.0
-3.6%
Effective tax rate
13.8%
18.1%
n/a
Net income
995
746
7.0
+33.4%
Net margin
15.0%
12.1%
0.1%
Diluted EPS
$5.45
$3.91
$0.04
+39.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
1,140
639
594
+78.4%
Capital expenditure
498
411
338
+21.2%
Free cash flow
642
228
256
+181.6%
Free cash flow margin
9.7%
3.7%
4.7%
Cash from investing
-487
-370
357
Cash from financing
-993
352
-396
Depreciation and amortisation
284
273
284
+4.0%
Share-based compensation
24.0
29.0
19.0
-17.2%
Buybacks
644
106
0.0
+507.5%
Dividends paid
148
22.0
22.0
+572.7%
Dividend per share
$0.67
$0.29
$0.12
+131.0%
Diluted shares, weighted
183m
191m
183m
-4.4%
Shares outstanding at period end
171m
183m
183m
-6.7%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
1,014
860
100
+17.9%
Non-controlling interest
6.0
5.0
4.0
+20.0%
Debt
3,959
4,112
3,591
-3.7%
Other liabilities
2,383
2,316
2,365
+2.9%
Total liabilities and equity
7,362
7,293
6,060
+0.9%
Fixed assets
3,291
3,008
2,784
+9.4%
Goodwill
n/a
153
153
Intangible assets
28.0
13.0
17.0
+115.4%
Cash and equivalents
1,201
1,556
902
-22.8%
Receivables
790
847
742
-6.7%
Inventory
1,147
935
767
+22.7%
Other assets
905
781
695
+15.9%
Total assets
7,362
7,293
6,060
+0.9%
10-K for the year ended 31 December 2018, filed 15 February 2019: the filing.